Capecitabine/Cyclophosphamide

卡培他滨/环磷酰胺

Report date: 2023/05/16 16:59:27

Base Information

Drug NameCapecitabine/Cyclophosphamide
Drug Alias NameCyclophosphamide/Capecitabine卡培他滨+环磷酰胺Capecitabine-Cyclophosphamide mixt卡培他滨-环磷酰胺Capecitabine and Cyclophosphamide +[10] 
ClassificationSmall molecules
Mechanisms of ActionAlkylating agentsThymidylate synthase inhibitorsDNA inhibitors
TargetsThymidylate synthaseDNA
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsYes CapecitabineCyclophosphamide
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancer

Other Information

ATC CodeN/A
Related LinksN/A